Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research supports early-career investigators' disrupted projects to sustain neurodegenerative research.
Funder: Alzheimer's Association
Due Dates: July 30, 2026 (LOI) | October 30, 2026 (LOI) | January 29, 2027 (LOI) | April 30, 2027 (LOI) | Within four weeks of invitation (full application)
Funding Amounts: Up to US$250,000 for 3–12 months; institutional cost-sharing of up to 25% of the requested budget
Summary: Bridge funding sustains early-career neurodegenerative research disrupted by changes in U.S. federal funding.
Key Information: Applicants must document a qualifying federal funding disruption; projects missed solely because of payline cutoffs are ineligible.
The Alzheimer's Association and The Michael J. Fox Foundation for Parkinson's Research run this bridge-funding program to protect research and career continuity amid changes in U.S. federal research funding. The Alzheimer's Association has partnered with the Robertson Foundation and other philanthropic partners to support the program.
Funding supports investigator and essential team salaries and other direct costs needed to continue affected U.S. or international projects. Research may focus on Alzheimer's disease, frontotemporal dementia, Parkinson's disease, dementia with Lewy bodies, atypical Parkinson's, or related disorders. The program targets early-career investigators whose work has been delayed, terminated or substantially cut, redirected by changed federal priorities, or left awaiting reapproval under new criteria.